Reyataz and Indigestion - a phase IV clinical study of FDA data

Summary:

Indigestion is reported as a side effect among people who take Reyataz (atazanavir sulfate), especially for people who are female, 40-49 old, have been taking the drug for 2 - 5 years also take Norvir, and have Ankylosing spondylitis.

The phase IV clinical study analyzes which people have Indigestion when taking Reyataz. It is created by eHealthMe based on reports of 11,228 people who have side effects when taking Reyataz from the FDA, and is updated regularly.

What is Reyataz?

Reyataz has active ingredients of atazanavir sulfate. It is often used in hiv infection. eHealthMe is studying from 11,386 Reyataz users. Check the latest studies of Reyataz.

What is Indigestion?

Indigestion is found to be associated with 2,430 drugs and 3,410 conditions by eHealthMe. Check the latest studies of Indigestion.

On Jul, 09, 2026

11,228 people reported to have side effects when taking Reyataz.
Among them, 44 people (0.39%) have Indigestion.

Among these 44 people:

How long have people been on Reyataz when they have Indigestion? *

What is the gender of people who have Indigestion when taking Reyataz? *

female: 54.29 %
male: 45.71 %

What is the age of people who have Indigestion when taking Reyataz? *

What are other drugs people take besides Reyataz? *

What are other side effects people have besides Indigestion? *

Nausea (feeling of having an urge to vomit): 15 people, 34.09%
Fatigue (feeling of tiredness): 13 people, 29.55%
Nausea And Vomiting: 11 people, 25.00%
Abdominal Pain Upper: 9 people, 20.45%
Diarrhea: 9 people, 20.45%
Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 9 people, 20.45%
Weight Decreased: 8 people, 18.18%
Back Pain: 7 people, 15.91%
Headache (pain in head): 7 people, 15.91%
Fever: 6 people, 13.64%

What are the existing conditions these people have? *

Ankylosing Spondylitis (type of arthritis affecting the spine): 6 people, 13.64%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 5 people, 11.36%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 5 people, 11.36%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 5 people, 11.36%
Pain: 4 people, 9.09%
Hepatic Neoplasm Malignant (liver cancer): 4 people, 9.09%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 6.82%
Nasopharyngitis (inflammation of the nasopharynx): 3 people, 6.82%
Vulvovaginal Mycotic Infection (vulvovaginal fungal infection): 2 people, 4.55%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Reyataz and have Indigestion?

- Check whether Indigestion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Reyataz:

Reyataz (11,386 reports)

Indigestion treatments and more:

Indigestion (445,029 reports)

Browse all side effects of Reyataz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Indigestion:

Indigestion (2,430 drugs)

Browse all the conditions that are associated with Indigestion:

Indigestion (3,410 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on atazanavir sulfate (the active ingredients of Reyataz) and Reyataz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.